2 years ago

Mendelian Secures £1.4M to Expand AI-Powered Rare Disease Diagnosis Tool

  • Mendelian, a London-based digital health company, has received over £1.4 million in funding from the Artificial Intelligence in Health and Care Awards

  • The company, led by Dr Peter Fish, has developed MendelScan, an AI case-finding tool, currently implemented in over 50 NHS primary care practices in England

  • The funding will be used to further develop and roll out MendelScan, allowing for real-world efficacy testing and exploring its potential for nationwide adoption across the UK's health service.

      • ProblemHealthcare

      "Mendelian is addressing the challenge of identifying and diagnosing rare disease patients more efficiently within the healthcare system."

      Solution

      "Mendelian has developed MendelScan, an AI case-finding tool designed to optimize the identification of patients with undiagnosed or unrecognized rare diseases in primary care settings."

      Covered on